This inventor holds 2 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Suntory Holdings Limited. Active years: 2017-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2021
Title: Shinya Fukizawa: Innovator in Lipid Metabolism and Uric Acid Management
Introduction
Shinya Fukizawa is a notable inventor based in Kyoto, Japan. He has made significant contributions to the fields of lipid metabolism and uric acid management through his innovative patents. With a total of 2 patents, Fukizawa's work is recognized for its potential impact on health and wellness.
Latest Patents
Fukizawa's latest patents include a lipid metabolism-promoting composition that features isoxanthohumol as an active ingredient. This invention aims to provide a composition that promotes lipid metabolism and suppresses fat accumulation. The composition is designed to be thermally stable and adequately water-soluble, making it effective in promoting lipid metabolism. Another significant patent is a uric acid-lowering agent that contains a tyrosine-containing cyclic dipeptide. This agent is effective in lowering uric acid levels and is useful in the prevention and treatment of conditions such as hyperuricemia and gout.
Career Highlights
Fukizawa is currently associated with Suntory Holdings Limited, a prominent company known for its contributions to the beverage and health industries. His work at Suntory has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Fukizawa collaborates with talented individuals such as Mai Yamashita and Toshihide Suzuki. Their combined expertise enhances the innovative capacity of their projects and contributes to the success of their endeavors.
Conclusion
Shinya Fukizawa's contributions to lipid metabolism and uric acid management through his patents reflect his commitment to advancing health solutions. His work continues to inspire innovation in the field, showcasing the importance of research and development in improving health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
